StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials (Preprint)
Authors:
- Stefan KonigorskiSKStefan Konigorski
- Sarah WernickeSWSarah Wernicke
- Tamara SlosarekTSTamara Slosarek
- Alexander M ZennerAZAlexander M Zenner
- Nils StrelowNSNils Strelow
- Darius F RuetherDRDarius F Ruether
- Florian HenschelFHFlorian Henschel
- Manisha ManaswiniMMManisha Manaswini
- Fabian PottbäckerFPFabian Pottbäcker
- Jonathan A EdelmanJEJonathan A Edelman
- Babajide OwoyeleBOBabajide Owoyele
- Matteo DanielettoMDMatteo Danieletto
Preprint
- 21 December 2021
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
UNSTRUCTURED N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- The mPower study, Parkinson disease mobile data collected using ResearchKitScientific Data, 2016
- How effective are common medications: a perspective based on meta-analyses of major drugsBMC Medicine, 2015
- CONSORT extension for reporting N-of-1 trials (CENT) 2015 StatementBMJ, 2015
- The PREEMPT study - evaluating smartphone-assisted n-of-1 trials in patients with chronic pain: study protocol for a randomized controlled trialTrials, 2015
- The Essential Guide to N-of-1 Trials in Health2015
- Experience of using an open source clinical trials data management software system in KenyaBMC Research Notes, 2014
- Revision of a method quality rating scale for single-case experimental designs andn-of-1 trials: The 15-item Risk of Bias inN-of-1 Trials (RoBiNT) ScaleNeuropsychological Rehabilitation, 2013
- Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug responseNature Reviews Drug Discovery, 2011
- The N-Of-1 Clinical Trial: The Ultimate Strategy For Individualizing Medicine?Personalized Medicine, 2011
- Clinical application of pharmacogeneticsTrends in Molecular Medicine, 2001